Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 6.7% in January

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the recipient of a large growth in short interest in January. As of January 31st, there was short interest totalling 44,300 shares, a growth of 6.7% from the January 15th total of 41,500 shares. Based on an average daily volume of 124,500 shares, the days-to-cover ratio is presently 0.4 days.

Wall Street Analyst Weigh In

Separately, Citigroup raised Fresenius SE & Co. KGaA to a “strong-buy” rating in a report on Friday, October 25th.

Fresenius SE & Co. KGaA Stock Down 2.1 %

Shares of Fresenius SE & Co. KGaA stock traded down $0.21 during trading on Monday, reaching $9.80. The company’s stock had a trading volume of 24,841 shares, compared to its average volume of 60,954. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. Fresenius SE & Co. KGaA has a 52-week low of $6.57 and a 52-week high of $10.15. The firm’s 50-day moving average is $9.21 and its two-hundred day moving average is $9.13.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.